Literature DB >> 10813294

Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms.

R Scarpa1, F Manguso, A D'Arienzo, F P D'Armiento, C Astarita, G Mazzacca, F Ayala.   

Abstract

OBJECTIVE: To evaluate colonic mucosa of patients with both active psoriasis and psoriatic arthritis (PsA) without bowel symptoms.
METHODS: Fifteen persons (9 men, 6 women) who had both active psoriasis and PsA without bowel symptoms underwent colonoscopy with multiple biopsies of bowel mucosa. Ten nonhospitalized healthy subjects in followup colonoscopy after resection of benign polyps (8 men, 2 women) took part as a control group.
RESULTS: Six psoriatic patients (40%) showed macroscopically normal colonic mucosa. In the remaining 9 reddening was frequently recorded (6 cases). while edema and granular changes appeared less commonly (3 cases each, respectively). Friability was markedly rare (only one case) and bleeding and ulcerations were absent. All 15 patients showed microscopic changes. Increase in lamina propria cellularity (consisting of plasma cells and lymphocytes) and lymphoid aggregates were found in all cases. Active inflammation, evident as neutrophilic polymorph infiltration occurred in 9 patients. Glandular atrophy was found in 3 cases; mucosal surface changes and crypt abnormalities occurred in one case each. No control had macroscopic or microscopic inflammatory changes of bowel mucosa.
CONCLUSION: Bowel mucosa of patients with PsA without bowel symptoms show microscopic lesions even when mucosa appeared macroscopically normal. This result may support a pathogenetic link between skin, joints, and gut in psoriatic patients with arthritis even in the absence of bowel symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 10813294

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  30 in total

1.  Fulminant ulcerative colitis associated with steroid-resistant minimal change disease and psoriasis: a case report.

Authors:  Ka-Ho Lok; Hiu-Gong Hung; Wai-Man Yip; Kin-Kong Li; Kam-Fu Li; Ming-Leung Szeto
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

2.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Jonathan S Levine; Robert Burakoff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

Review 3.  The intestinal microbiome in spondyloarthritis.

Authors:  Tejpal Gill; Mark Asquith; James T Rosenbaum; Robert A Colbert
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

4.  Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.

Authors:  Jose U Scher; Carles Ubeda; Alejandro Artacho; Mukundan Attur; Sandrine Isaac; Soumya M Reddy; Shoshana Marmon; Andrea Neimann; Samuel Brusca; Tejas Patel; Julia Manasson; Eric G Pamer; Dan R Littman; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

Review 5.  Psoriatic arthritis and psoriasis: differential diagnosis.

Authors:  Maddalena Napolitano; Francesco Caso; Raffaele Scarpa; Matteo Megna; Angela Patrì; Nicola Balato; Luisa Costa
Journal:  Clin Rheumatol       Date:  2016-05-07       Impact factor: 2.980

6.  Reply: To PMID 25319745.

Authors:  Jose U Scher; Soumya Reddy; Carles Ubeda; Andrea Neimann; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

Review 7.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

8.  Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.

Authors:  Maddalena Napolitano; Luisa Costa; Francesco Caso; Matteo Megna; Raffaele Scarpa; Nicola Balato; Fabio Ayala; Anna Balato
Journal:  Clin Rheumatol       Date:  2017-05-31       Impact factor: 2.980

9.  Extra-articular manifestations in psoriatic arthritis patients.

Authors:  Rosario Peluso; Salvatore Iervolino; Maria Vitiello; Vincenzo Bruner; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2014-05-08       Impact factor: 2.980

10.  Psoriatic arthritis: pharmacoeconomic considerations.

Authors:  Ignazio Olivieri; Lorenzo Giovanni Mantovani; Salvatore D'Angelo; Angela Padula; Simona de Portu
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.